MACULAR DEGENERATION || Public Health Genomics Knowledge Base (v1.2)

Public Health Genomics Knowledge Base (v1.2)




Last Posted: Feb 09, 2017

---

• Facts About Age-Related Macular Degeneration
  NIH, National Eye Institute
• A Value-Based Medicine cost-utility analysis of genetic testing for neovascular macular degeneration.
  Brown Gary C et al. International journal of retina and vitreous 2015 119
• Genetic screening for neovascular AMD: cost effective…not so quick.
  Reichel Elias et al. International journal of retina and vitreous 2015 124
• AMD and the alternative complement pathway: genetics and functional implications
  PL Tan et al, BMC Human Genomics, July 2016
• Alternative RNA splicing: contribution to pain and potential therapeutic strategy.
  Donaldson Lucy F et al. Drug discovery today 2016 Jun
• Risk factors and biomarkers of age-related macular degeneration.
  Lambert Nathan G et al. Progress in retinal and eye research 2016 May
• The Application of Genetic Risk Scores in Age-Related Macular Degeneration: A Review.
  Cooke Bailey Jessica N et al. Journal of clinical medicine 2016 5(3)
• Learn About Age-Related Macular Degeneration
  Her father lost vision in one eye
• Genetic epidemiology with a capital E, ten years after.
  Khoury Muin J et al. Genetic epidemiology 2011 Dec 35(8) 845-52
• Current landscape of direct-to-consumer genetic testing and its role in ophthalmology: a review.
  Sanfilippo Paul G et al. Clinical & experimental ophthalmology 2015 Aug 43(6) 578-90
• Age-related macular degeneration: Complement in action.
  van Lookeren Campagne Menno et al. Immunobiology 2015 Dec
• Who is at risk for age-related macular degeneration
  National Eye Institute
• Dietary profile of patients with Stargardt's disease and Retinitis Pigmentosa: is there a role for a nutritional approach?
  Sofi Francesco et al. BMC ophthalmology 2016 (1) 13
• Let there be light: gene and cell therapy for blindness.
  Dalkara Deniz et al. Human gene therapy 2016 Jan
• A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration.
  Lorés-Motta Laura et al. Pharmacogenetics and genomics 2016 Jan (1) 20-7
• A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants
  LG Fritsche et al, Nature Genetics, December 21, 2015

more